Opinion on Therapy Area in Europe

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Myriad Genetics: an unusually successful collaborator

Published By Datamonitor
23 Oct 2000
CommentWire
CommentWire

Antisoma: changing product range, but not direction

Published By Datamonitor
30 Oct 2000
CommentWire
CommentWire

Glaxo Wellcome: taking some of the tension out of anti-hypertension

Published By Datamonitor
01 Nov 2000
CommentWire
CommentWire

ADHD: NICE ruling for Ritalin, but will it boost sales?

Published By Datamonitor
02 Nov 2000
CommentWire
CommentWire

KS BioMedix: an alternative route to the marketplace

Published By Datamonitor
06 Nov 2000
CommentWire
CommentWire

Multiple sclerosis: NICE to reconsider decision

Published By Datamonitor
09 Nov 2000
CommentWire
CommentWire

Raisio: Benecol isn't beneficial to the bottom line

Published By Datamonitor
09 Nov 2000
Expert View
Expert View

Opening the door to Japanese markets

Published By Datamonitor
08 Dec 2000
CommentWire
CommentWire

Shire Pharmaceuticals: transatlantic growth spurt

Published By Datamonitor
11 Dec 2000
CommentWire
CommentWire

Vernalis: benefiting from SB's regulatory headaches

Published By Datamonitor
14 Dec 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.